Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples